Insilico signs US$888 million AI drug-development deal days after Hong Kong IPO
The deal comes just days after the US company’s shares debuted following its initial public offering (IPO), which raised HK$2.28 billion (US$293 million) after the public portion was oversubscribed 1,427 … Read More